## Clinical Presentation Analysis This patient presents with: - Recurrent venous thromboembolism (DVT + PE) - Normal routine coagulation studies - Mild splenomegaly - No obvious acquired risk factors This clinical picture is highly suggestive of **antiphospholipid syndrome (APS)**, a thrombophilia characterized by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies. ## Why Antiphospholipid Antibody Testing? **Key Point:** Antiphospholipid syndrome is the most common **acquired thrombophilia** and accounts for 5–15% of recurrent venous thromboembolism cases in young patients without traditional risk factors. **High-Yield:** The diagnostic criteria for APS require: 1. Clinical criterion: thrombosis (venous or arterial) or pregnancy morbidity 2. Laboratory criterion: LAC, aCL (IgG or IgM), or anti-β~2~-glycoprotein-I antibodies on ≥2 occasions ≥12 weeks apart **Clinical Pearl:** Splenomegaly in a thrombophilic patient should raise suspicion for APS or other autoimmune thrombotic disorders. The normal routine coagulation studies do NOT exclude APS — in fact, the LAC paradoxically *prolongs* the aPTT in vitro but causes thrombosis in vivo. ## Investigation Hierarchy for Thrombophilia Workup | Investigation | Indication | Sensitivity in APS | |---|---|---| | LAC and aCL | Recurrent VTE + normal PT/aPTT; suspected APS | 80–90% | | APCR/Factor V Leiden | First VTE, family history, or young age | Common but not present here | | Prothrombin G20210A | Heterozygous carriers; less common | Lower pretest probability | | Antithrombin/Protein C/S | Deficiency states; rarer | Not suggested by presentation | **Mnemonic:** **APS** = **A**ntiphospholipid **P**rotein **S**yndrome — remember the three main antibodies: **LAC**, **aCL**, **anti-β~2~-GPI**. ## Diagnostic Approach ```mermaid flowchart TD A[Recurrent VTE + Normal PT/aPTT]:::outcome --> B{Clinical context?}:::decision B -->|No obvious acquired risk| C[Suspect inherited or acquired thrombophilia]:::outcome C --> D{Splenomegaly or autoimmune features?}:::decision D -->|Yes| E[Test for APS first: LAC + aCL]:::action D -->|No| F[Test for inherited: Factor V Leiden, PT G20210A]:::action E --> G[LAC/aCL positive?]:::decision G -->|Yes| H[Repeat testing at 12 weeks for diagnosis]:::action G -->|No| F ``` ## Next Steps If LAC/aCL testing is positive, repeat testing ≥12 weeks later to confirm diagnosis. Initiate anticoagulation (warfarin target INR 2–3, or DOAC with caution) pending confirmation.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.